Trial is under way for SynapDx's early autism test

05/10/2013 | American City Business Journals

SynapDx is conducting a clinical trial to test its blood-based assay in diagnosing autism in children 18 months or older. The trial, launched last month, involves 660 children at 20 clinical sites. The average age at which autism is detected is 4.5 years, and earlier detection would allow earlier treatment.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY